Sign in →

Test Code LAB4117 HEPATITIS A ANTIBODY, IGM

Specimen Type

Preferred Sample: Serum (Gold/SST/Red/Tiger Top Tube)

Alternate Sample: Lithium Heparin Plasma (Light Green/Dark Green Top Tube)

Specimen Volume

1 mL

Minimum Volume

0.5 mL

Turnaround Time

STAT: 1 hour

Timed: 4 hours

Routine: 4 hours

Test Schedule

Daily

Sample Stability

Room Temperature: 3 days

Refrigerated: 7 days

Frozen: N/A

Method

Chemiluminescent microparticle immunoassay (CMIA)

Synonyms

HAVIGM

LAB4117

ANTI-HAV IGM

HEPATITIS A IGM

HEPATITIS A ANTIBODY

CPT Codes

86709

Reference Range

Nonreactive

Clinical Information

The hepatitis A virus is an RNA containing virus that lacks an envelope. It belongs to the family of picornaviruses. To date, just one human serotype and seven genotypes have been described. The viral capsid consists of three proteins (VP1-VP3) that form an immunodominant structure on the surface of the viral particle that is highly conserved between all genotypes. After vaccination or natural infection, the immune response is directed against this structure. Hepatitis A is the most common form of acute viral hepatitis. It is transmitted by the fecal-oral route. Hepatitis A is typically a self-limiting disease and is often a subclinical disorder, particularly in children.

 

Symptomatic hepatitis A virus (HAV) infections can be clinically indistinguishable from infection with hepatitis B or C virus therefore serological testing is an important tool for proper diagnosis. An acute or recently acquired HAV infection can be assumed if anti-HAV IgM antibodies are detected. Anti-HAV IgM antibodies can always be detected at the onset of the disease and usually disappear 3 to 4 months later; however, IgM antibodies may be detected in some patients for a longer period. HAV IgM antibodies develop only very rarely after vaccination.